BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26089843)

  • 1. Comparison of clinical outcomes between culprit vessel only and multivessel percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel coronary diseases.
    Ryu KS; Park HW; Park SH; Shon HS; Ryu KH; Lee DG; Bashir ME; Lee JH; Kim SM; Lee SY; Bae JW; Hwang KK; Kim DW; Cho MC; Ahn YK; Jeong MH; Kim CJ; Park JS; Kim YJ; Jang YS; Kim HS; Seung KB;
    J Geriatr Cardiol; 2015 May; 12(3):208-17. PubMed ID: 26089843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock.
    Lee JM; Rhee TM; Hahn JY; Kim HK; Park J; Hwang D; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Kim YJ; Chae SC; Cho MC; Kim CJ; Gwon HC; Kim JH; Kim HS; Jeong MH;
    J Am Coll Cardiol; 2018 Feb; 71(8):844-856. PubMed ID: 29471935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culprit-Lesion-Only Versus Multivessel Revascularization Using Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: A Korean Acute Myocardial Infarction Registry-Based Analysis.
    Jo HS; Park JS; Sohn JW; Yoon JC; Sohn CW; Lee SH; Hong GR; Shin DG; Kim YJ; Jeong MH; Chae SC; Hur SH; Hong TJ; Seong IW; Chae JK; Rhew JY; Chae IH; Cho MC; Bae JH; Rha SW; Kim CJ; Choi DH; Jang YS; Yoon JH; Chung WS; Seung KB; Park SJ
    Korean Circ J; 2011 Dec; 41(12):718-25. PubMed ID: 22259602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry.
    Galvão Braga C; Cid-Álvarez AB; Redondo Diéguez A; Trillo-Nouche R; Álvarez Álvarez B; López Otero D; Ocaranza Sánchez R; Gestal Romaní S; González Ferreiro R; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):425-432. PubMed ID: 27825718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Patients With Non-ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock.
    Omer MA; Brilakis ES; Kennedy KF; Alkhouli M; Elgendy IY; Chan PS; Spertus JA
    JACC Cardiovasc Interv; 2021 May; 14(10):1067-1078. PubMed ID: 33933384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Revascularization Strategy in Non-ST-Segment-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease: Culprit-Only Versus One-Stage Versus Multistage Revascularization.
    Kim MC; Hyun JY; Ahn Y; Bae S; Hyun DY; Cho KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Kim HS; Gwon HC; Seong IW; Hwang KK; Chae SC; Hur SH; Cha KS; Oh SK
    J Am Heart Assoc; 2020 Aug; 9(15):e016575. PubMed ID: 32750302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivessel vs. culprit vessel-only percutaneous coronary intervention in ST-segment elevation myocardial infarction with and without cardiogenic shock.
    Wu J; Wang Y; Li C; Ji H; Zhao W; Tong Q; Zhang M
    Front Cardiovasc Med; 2022; 9():992456. PubMed ID: 36505378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI.
    Hlinomaz O; Motovska Z; Kala P; Hromadka M; Precek J; Mrozek J; Červinka P; Kettner J; Matejka J; Zohoor A; Bis J; Jarkovsky J
    Hellenic J Cardiol; 2024; 76():1-10. PubMed ID: 37633488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
    Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
    JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Culprit vessel only versus "one-week" staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction.
    Ma LX; Lu ZH; Wang L; Du X; Ma CS
    J Geriatr Cardiol; 2015 May; 12(3):226-31. PubMed ID: 26089845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year clinical outcomes between biodegradable-polymer-coated biolimus-eluting stent and durable-polymer-coated drug-eluting stents in STEMI patients with multivessel coronary artery disease undergoing culprit-only or multivessel PCI.
    Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Atherosclerosis; 2019 May; 284():102-109. PubMed ID: 30877937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.
    Hannan EL; Samadashvili Z; Walford G; Holmes DR; Jacobs AK; Stamato NJ; Venditti FJ; Sharma S; King SB
    JACC Cardiovasc Interv; 2010 Jan; 3(1):22-31. PubMed ID: 20129564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revascularization Strategies in Patients With STEMI: Culprit-Only vs Multivessel Revascularization Using Percutaneous Coronary Intervention.
    Alsadat N; Hyun K; D'Souza M; Chew D; Weaver J; Juergens C; Kritharides L; Hammett C; Brieger D
    J Invasive Cardiol; 2019 Nov; 31(11):314-318. PubMed ID: 31303602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization.
    Kim MC; Jeong MH; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Cho SY; Rha SW; Bae JH; Cho JG; Park SJ;
    Int J Cardiol; 2011 Dec; 153(2):148-53. PubMed ID: 20843572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational Study.
    Ibrahim H; Sharma PK; Cohen DJ; Fonarow GC; Kaltenbach LA; Effron MB; Zettler ME; Peterson ED; Wang TY
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of infarct-related artery vs multivessel revascularization in ST-segment elevation myocardial infarction with multivessel disease: analysis from Korea Acute Myocardial Infarction Registry.
    Lee HW; Hong TJ; Yang MJ; An SG; Oh JH; Choi JH; Lee HC; Cha KS; Hong JY;
    Cardiol J; 2012; 19(3):256-66. PubMed ID: 22641544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease.
    Fukutomi M; Toriumi S; Ogoyama Y; Oba Y; Takahashi M; Funayama H; Kario K
    Catheter Cardiovasc Interv; 2019 Apr; 93(5):E262-E268. PubMed ID: 30244539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary intervention for nonculprit vessels in cardiogenic shock complicating ST-segment elevation acute myocardial infarction.
    Yang JH; Hahn JY; Song PS; Song YB; Choi SH; Choi JH; Lee SH; Jeong MH; Choi DJ; Kim YJ; Gwon HC
    Crit Care Med; 2014 Jan; 42(1):17-25. PubMed ID: 24105454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London.
    Iqbal MB; Ilsley C; Kabir T; Smith R; Lane R; Mason M; Clifford P; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; MacCarthy P; Dalby M;
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):936-43. PubMed ID: 25371542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.